Metabolic disease
Conditions
Interventions
200ml - pivot energy group:Oral administration of 200ml of Zuneng 2h before operation
400ml - pivot energy group:Oral administration of 400ml of Zuneng 2h before operation
Sponsors
Affiliated Hospital of Xuzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Patients who plan to undergo daytime laparoscopic cholecystectomy or laparoscopic hernia repair; (2) 18-65 years old, regardless of gender; (3) ASA Class I-II; (4) BMI 18-30kg/m^2 (5) Informed consent, voluntarily participate in the test, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with serious heart, brain, lung, liver, kidney and metabolic diseases; (2) Patients with previous history of gastric cancer surgery, complicated abdominal surgery or gastrointestinal diversion surgery; (3) ECG showed that the heart rate was180mmHg and/or diastolic blood pressure>110mmHg in patients with hypertension or<90/60mmHg in patients with hypotension before operation; (5) Subjects have serious communication disorder caused by severe hearing deterioration; (6) Pregnant or lactating women; (7) Diabetes with unstable blood sugar and diabetes related complications; (8) Subjects who are not suitable to participate in this study;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Insulin resistance; | — |
Countries
China
Contacts
Public ContactZhiping Wang
Affiliated Hospital of Xuzhou Medical University
Outcome results
None listed